EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Applied Therapeutics Inc. (APLT) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-21.82M |
|
-- |
|
-- |
|
$25.52M |
|
$-25.52M |
|
$3.70M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-21.82M |
|
$-25.52M |
|
$-25.42M |
|
144.79M |
|
144.79M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$53.97M |
|
-- |
|
$2.94M |
|
$56.91M |
|
$17.96M |
|
-- |
|
$2.27M |
|
$20.24M |
|
$36.67M |
|
$36.67M |
|
$36.67M |
|
141.58M |
|
| Cash Flow Statement Financials | |
$-28.64M |
|
-- |
|
-- |
|
$79.40M |
|
$50.76M |
|
$-28.64M |
|
$1.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-28.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.52% |
|
-59.52% |
|
-38.35% |
|
-59.52% |
|
$0.26 |
|
$-0.20 |
|
$-0.20 |
|